CMP (Rs) 775 Upside/ (Downside) (%) (1.4) Market Cap. (Rs bn) 11.4 Free Float (%) 35.0 Shares O/S (mn) 14.7

Similar documents
CMP* (Rs) 242 Upside/ (Downside) (%) 2. Market Cap. (Rs bn) 157 Free Float (%) 65.6 Shares O/S (mn) 630

CMP* (Rs) 1,458 Upside/ (Downside) (%) 10 Bloomberg Ticker. ABB IN Market Cap. (Rs bn) 309 Free Float (%) 25 Shares O/S (mn) 212

CMP* (Rs) 208 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) Free Float (%) 65.6 Shares O/S (mn) 630

CMP* (Rs) 166 Upside/ (Downside) (%) 28 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,361 Free Float (%) 37.7 Shares O/S (mn) 8,245

CMP* (Rs) 336 Upside/ (Downside) (%) 21 Bloomberg Ticker. MOIL IN Market Cap. (Rs bn) 45 Free Float (%) 24 Shares O/S (mn) 133

CMP* (Rs) 840 Upside/ (Downside) (%) (2.4) Bloomberg Ticker Market Cap. (Rs bn) 379 Free Float (%) 53 Shares O/S (mn) 451.6

CMP* (Rs) 263 Upside/ (Downside) (%) 7.3. Market Cap. (Rs bn) 635 Free Float (%) 59 Shares O/S (mn) 2,417

BUY NCC. An Ordinary Quarterly Performance; Maintain BUY. Target Price: Rs98. Institutional Equity Research. 4QFY17 Result Update May 24, 2017

Titan Company BUY. Back to Value Zone Validate Rating Upgrade. Institutional Equity Research. November 05, Target Price Rs428.

CMP* (Rs) 161 Upside/ (Downside) (%) 19 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,329 Free Float (%) 30.3 Shares O/S (mn) 8,245

CMP (Rs) 249 Upside/ (Downside) (%) Market Cap. (Rs bn) 25.5 Free Float (%) 29.7 Shares O/S (mn) 102.3

Nestlé India Outlook Hazy; Valuations Prohibitive

CMP* (Rs) 417 Upside/ (Downside) (%) 46 Bloomberg Ticker. SUNP IN Market Cap. (Rs bn) 1,001 Free Float (%) 46 Shares O/S (mn) 2399

CMP* (Rs) 172 Upside/ (Downside) (%) 11.6 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,414 Free Float (%) 30.3 Shares O/S (mn) 8,245

HOLD ACC. Strong Performance on Better Volume and Firm Realizations. Target Price: Rs1,640. Institutional Equity Research

HOLD. Nestle. Good Performance Irrespective of GST Pangs. Target Price: Rs6,624. Institutional Equity Research. 2QCY17 Result Update July 27,2017

CMP* (Rs) 1,033 Upside/ (Downside) (%) (0.3) Bloomberg Ticker Market Cap. (Rs bn) 467 Free Float (%) 53 Shares O/S (mn) 452

CMP* (Rs) 205 Upside/ (Downside) (%) 12 Bloomberg Ticker. NACO IN Market Cap. (Rs bn) 29 Free Float (%) 27 Shares O/S (mn) 143

CMP* (Rs) 360 Upside/ (Downside) (%) 25. Market Cap. (Rs bn) 38 Free Float (%) 76 Shares O/S (mn) 104.5

BUY NTPC. Higher Regulated Equity to Aid Profitability; Maintain BUY. Target Price: Rs192. Institutional Equity Research

CMP* (Rs) 203 Upside/ (Downside) (%) 23. Market Cap. (Rs bn) 116 Free Float (%) 61 Shares O/S (mn) 572

CMP* (Rs) 346 Upside/ (Downside) (%) 17. Market Cap. (Rs bn) 23 Free Float (%) 42.0 Shares O/S (mn) 67

BUY CDSL. Strong Operating Performance; Maintain BUY. Target Price: Rs435. Institutional Equity Research. 2QFY18 Result Update October 31, 2017

CMP* (Rs) 1,464 Upside/ (Downside) (%) 10. Market Cap. (Rs bn) 91 Free Float (%) 55 Shares O/S (mn) 62

CMP (Rs) 326 Upside/ (Downside) (%) 24. Market Cap. (Rs bn) 21.7 Free Float (%) 42.0 Shares O/S (mn) 67

CMP* (Rs) 237 Upside/ (Downside) (%) 29 Bloomberg Ticker. APTY IN Market Cap. (Rs bn) 136 Free Float (%) 55.9 Shares O/S (mn) 509

CMP (Rs) 702 Upside/ (Downside) (%) 42 Bloomberg Ticker. JKCE IN Market Cap. (Rs bn) 54 Free Float (%) 42 Shares O/S (mn) 77.3

CMP* (Rs) 1,424 Upside/ (Downside) (%) 19 Bloomberg Ticker Market Cap. (Rs bn) 268 Free Float (%) 46 Shares O/S (mn) 188

BUY. DCB Bank. Improving Capital Consumption to Aid Returns; Maintain BUY. Target Price: Rs202. Institutional Equity Research

CMP (Rs) 133 Upside/ (Downside) (%) 35 Bloomberg Ticker. ICEM IN Market Cap. (Rs bn) 41 Free Float (%) 71.6 Shares O/S (mn) 308.1

KNR Constructions Robust Performance on Execution Ramp-up

CMP* (Rs) 198 Upside/ (Downside) (%) 12. Market Cap. (Rs bn) 61 Free Float (%) 84 Shares O/S (mn) 308

CMP* (Rs) 189 Upside/ (Downside) (%) (1) Bloomberg Ticker PNB IN Market Cap. (Rs bn) 402 Free Float (%) 38 Shares O/S (mn) 2,128

CMP* (Rs) 289 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) 30 Free Float (%) 69 Shares O/S (mn) 105

CMP* (Rs) 145 Upside/ (Downside) (%) 32 Bloomberg Ticker BOB IN Market Cap. (Rs bn) 384 Free Float (%) 36 Shares O/S (mn) 2,646

Sonata Software HOLD. Unimpressive Show; IITS Revenue Disappoints. Institutional Equity Research. February 06, Target Price Rs190.

CMP (Rs) 166 Upside/ (Downside) (%) (1) Bloomberg Ticker Market Cap. (Rs bn) 125 Free Float (%) 37 Shares O/S (mn) 726

Aurobindo Pharma. Institutional Equity Research. Sector - Pharmaceuticals. RSec TradEdge India. March 02, 2017

Power Mech Projects. Institutional Equities. 2QFY18 Result Update BUY. Strong Business Scalability Likely; Retain Buy

CMP* (Rs) 301 Upside/ (Downside) (%) 25. Market Cap. (Rs bn) 19.6 Free Float (%) 26 Shares O/S (mn) 65

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution

KEC International. Recovering from a weak phase. Institutional Equity Research. Order inflow traction remains intact

Jubilant FoodWorks. Institutional Equity Research. Sector - FMCG. RSec TradEdge India. January 17, 2017

Visaka Industries Ltd

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

Institutional Equities

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

Amber Enterprises India Ltd

Fineotex Chemical Ltd

Jamna Auto Industries

Cummins India Ltd Bloomberg Code: KKC IN

GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart

Colgate-Palmolive (India)

Gillette India. Institutional Equities. 1QFY18 Result Update

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

Ahluwalia Contracts (India)

Thermax. Institutional Equities. 3QFY18 Result Update. Healthy Execution, But Margins Disappoint SELL

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

TTK Prestige Ltd. Result Highlights. Revenue growth of 41% YoY, shows no slowdown yet. OPM at ~15.8%; in line with our estimate

Simplex Infrastructures

Robust results, TLT margins improved profitability.

Balkrishna Industries

Hindustan Unilever (RHS)

Initiating Coverage. Uflex Ltd.

Transport Corporation of India Ltd.

KEC International Ltd.

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1%

Hindustan Media Ventures

BUY. NTPC Ltd Power RETAIL EQUITY RESEARCH

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

Inox Wind BUY. Performance Highlights. CMP Target Price `390 `505. 2QFY2016 Result Update Capital Goods. 3 year price chart

SQS India BFSI Ltd HOLD. Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E

Music Broadcast BUY. Performance Update. CMP Target Price `293 `475. 3QFY2019 Result Update Media. Stock Info Sector Market Cap (Rs cr) Media

EBITDA 5,076 3, , EBITDA

Key estimate revision. Financial summary. Year FY14 391,088 45,198 34, FY15E 354,262 35,426 23,

Indian Oil Corporation

Transport Corporation of India Ltd.

Music Broadcast BUY. Performance Update. CMP Target Price `329 `475. 2QFY2019 Result Update Media. Historical share price chart.

Larsen & Toubro Ltd.

Swaraj Engines. Institutional Equities. 2QFY18 Result Update ACCUMULATE

HOLD. Coal India Ltd Coal RETAIL EQUITY RESEARCH. Uncertainty remains. GEOJIT BNP PARIBAS Research

Parag Milk Foods BUY. Performance Update CMP. `256 Target Price `330. 2QFY2019 Result Update Dairy Products. Investment Period 12 Months

MCX Ltd. Rating: Target price: EPS: Tepid volume growth continues. Target. Rating CMP. Rs. 1,080 SELL. Rs. 1,176

Maruti Suzuki India BUY. Performance Update. CMP `9,315 Target Price `10,820. 1QFY2019 Result Update Automobile. Historical share price chart

Strides Arcolab. Inline 4Q, recent acquisitions to deepen asset growth. Institutional Equity Research. Strides Arcolab. Pharmaceuticals India

Colgate-Palmolive. Q2FY18 Result Update Volume pressure continues; Soft A&P aids Margin. Sector: FMCG CMP: ` 1,063. Recommendation: HOLD

Rallis India SELL. Performance Highlights. `231 Target Price 189 CMP. 2QFY2018 Result Update Agrichemical. Investment Period 12 months

Mahindra & Mahindra Ltd.

TV Today Network BUY. Performance Update CMP. `323 Target Price `498. 3QFY2019 Result Update Media. Investment Period 12 Months

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E

Dalmia Bharat Enterprises

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

Mahindra & Mahindra Ltd.

Adani Ports & SEZ Rating: Target price: EPS:

Sonata Software BUY. Laying the Platform for Growth. Institutional Equity Research. December 01, Target Price Rs185.

Colgate-Palmolive. Q1FY18 Result Update Volume pressure continues; Soft A&P aids Margin. Sector: FMCG CMP: ` 1,083. Recommendation: HOLD

Amara Raja Batteries BUY. Performance Highlights. CMP `1,010 Target Price `1,167. 2QFY2017 Result Update Auto Ancillary. 3-year price chart

HCC BUY. Infrastructure April 10, QIP step in the right direction EVENT UPDATE. India Research. Bloomberg: HCC IN Reuters: HCNS.

Quick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart.

Transcription:

2QFY18 Result Update November 23, 2017 Market Cap. (Rs bn) 11.4 Free Float (%) 35.0 Shares O/S (mn) 14.7 High Order Book Provides Revenue Visibility (PMPL) has delivered a healthy performance in 2QFY18. Its consolidated revenue rose by 6.3% YoY to Rs3.5bn (vs. our estimate of Rs3.6bn) owing to strong growth in Civil & Other Works and O&M businesses. However, ETC revenue dipped by 15.5% YoY to Rs1.4bn owing to GST-led execution delay and lower domestic thermal power capacity addition. Looking ahead, we believe dominant position in power EPC business, impressive order book and superior execution capabilities will drive PMPL s profitability. Assigning higher multiple (11x P/E of FY19E from 9x earlier) owing to strong traction in order book and improving margin profile, we maintain our recommendation on the stock with a revised Target Price of Rs764 (from Rs578 earlier). Civil & Other Works Biz Aids 6.2% YoY Growth in Consolidated Revenue PMPL s consolidated revenue grew by 6.2% YoY to Rs3.4bn on the back strong 85.9% YoY and 9.6% YoY growth in Civil & Other Works and O&M business to Rs766mn and Rs1.2bn, respectively. Led by GST-led execution delay and slowdown in domestic thermal power capacity addition, its ETC revenue declined by 15.5% YoY to Rs1.4bn. Margin Improves; PAT Records a Decent Growth EBITDA margin expanded by 45bps YoY to 13.1% owing to higher contribution from high-margin Civil & Other Works and O&M business. PMPL expects margins continue to improve with the shifting of revenue-mix shift towards high-margin O&M services segment. Led by better execution and improved margin, PMPL s PAT grew by 22.0% YoY to Rs192mn. The Management expects that the working capital cycle which elongated in 1HFY18 due to GST-led delay and receivables to normalise in next 1-2 quarters. Order Book Continues to Remain Robust PMPL secured orders worth Rs7.5bn and Rs1.1bn in ETC segment and O&M segment, respectively in 1HFY18. ETC orders include: orders worth Rs6.24bn from international market (Rs4.91bn in Nigeria and Rs1.33bn in Bahrain). Its order book stands at Rs41.6bn (3xFY17 sales) as of Nov 17, which provides a healthy revenue visibility for next 2-3 years. Further, while its ETC order book stands at Rs21.4bn (3.5xFY17 revenues), O&M segment s order book remains strong at Rs11.4bn (2xFY17 revenues) accounting for 27% contribution to total order book. In Civil & Other Works segment, its order book stands at Rs8.8bn (4.5xFY17 sales). The Management expects order backlog of Rs50bn by Mar 18 compared to Rs37bn in Mar 17. Outlook & Valuation Looking ahead, we believe that PMPL will deliver higher profitability on the back of dominant position in power EPC business, impressive order book and superior execution capabilities. Notably, the stock has witnessed a sharp rally since our initiation report with BUY recommendation in Feb 17. We maintain our recommendation on the stock with an upwardly revised Target Price of Rs764 (11x P/E of FY19E). Key Financials (Rs mn) FY16 FY17 FY18E FY19E Net sales 13,782 13,382 15,166 17,158 PAT 753 646 852 1,022 EPS (Rs) 51.2 43.9 57.9 69.5 PE (x) 15.1 17.6 13.4 11.2 EV/EBITDA (x) 7.7 8.3 7.0 6.1 Book value (Rs/share) 377.3 422.0 478.9 547.3 P/BV (x) 2.1 1.8 1.6 1.4 ROCE 17.2 14.8 16.2 16.9 Source: Company, RSec Research Share Price (%) 1 mth 3 mth 12 mth Absolute Performance 35.9 44.3 73.0 Relative to Nifty 34.9 39.5 43.5 Shareholding Pattern (%) Jun 17 Sept'17 Promoter 65.1 65.0 Others 34.9 35.0 1 Year Stock Price Performance 800 750 700 650 600 550 500 450 400 350 Nov-16 Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Aug-17 Sep-17 Oct-17 Nov-17 Research Analyst : Rupesh Sankhe Contact : (022) 33201606 Email : rupesh.sankhe@relianceada.com 1

Risks to the View ff Downside Risks: Lower-than-expected growth in order book and insufficient cash flows. ff Upside Risks: Meaningful recovery in ETC business owing to higher thermal power capacity addition and higher-than-expected growth in order book. Exhibit 1: Quarterly Performance (Rs mn) 2QFY18 1QFY18 QoQ (%) 2QFY17 YoY (%) 6MFY18 6MFY17 YoY Net Sales 3,451.9 3,583.8 (3.7) 3,247.3 6.3 7035.6 6504.2 8.2 Operating Costs 3,001.0 3,124.6 (4.0) 2,838.1 5.7 6125.5 5675.3 7.9 EBITDA 450.9 459.2 (1.8) 409.3 10.2 910.1 828.9 9.8 EBITDA Margin (%) 13.1 12.8 12.9 12.7 Other Income 19.4 28.0 (30.7) 15.0 29.4 583.3 500.9 16.5 Interest 86.8 76.1 14.0 75.9 14.3 162.9 162.6 0.2 Depreciation 109.0 102.4 6.4 102.4 6.5 211.4 208.0 1.6 Profit Before Tax 274.6 308.7 (11.1) 246.0 11.6 583.3 500.9 16.5 Tax 81.7 94.5 (13.6) 88.7 (7.90 176.2 178.0 Tax Rate (%) 29.8 30.6 36.0 0.3 0.4 Share of profit/loss in associates (0.5) (0.5) 0.4 (0.5) 3.5 Minority Interest 0.0 0.0 0.0 Rep PAT 192.4 214.2 (10.2) 157.7 22.0 406.6 326.4 24.6 Source: Company, RSec Research 2

Profit & Loss Net sales 13,782 13,382 15,166 17,158 % yoy change 0.9 (2.9) 13.3 13.1 Raw Material cost 1,149 1,216 1,385 1,575 Employee expenses 1,549 2,265 2,457 2,763 Other expenses 275 313 344 392.9 Contract execution expenses 8,989 7,928 9,016 10,209 Total operating expenditure 11,963 11,722 13,202 14,940 EBITDA 1,820 1,660 1,964 2,219 EBITDA margin (%) 13.2 12.4 13.0 12.9 Depreciation 390 410 463 515 EBIT 1,430 1,250 1,501 1,703 Other income 55 77 80 83 Interest costs 329 329 320 296 PBT 1,156 998 1,261 1,491 Taxes 406 357 416 477 Minority interest 3 6 7 8 Adjusted PAT 753 646 852 1,022 Balance Sheet Liabilities Share capital 147 147 147 147 Reserves & Surplus 5,404 6,060 6,897 7,904 Total shareholder's funds 5,551 6,207 7,044 8,051 Secured loans 214 155 155 155 Unsecured loans 1,919 1,643 1,388 1,103 Total borrowings 2,132 1,797 1,542 1,257 Other long term liabilities 907 946 1,116 1,250 Deferred tax liability 42 21 21 21 Minority interest 4 21 21 21 Capital employed 8,637 8,993 9,746 10,602 Gross Block 3,960 4,431 4,981 5,541 Accumulated Depreciation 1,987 2,398 2,861 3,376 Net Block 1,973 2,032.8 2,120 2,164 Capital Work in Progress 220 119 140 110 Investments (non current) 3.1 9.1 9.1 9.1 Inventories 313 490 496 562 Sundry Debtors 2,727 2,948 3,033 3,364 Cash and Bank 432 348 347 365 Loans and Advances 5,583 5,624 6,218 6,692 Other Current Assets 1,761 2,008 2,053 2,108 Total Current Assets 10,816 11,418 12,147 13,091 Current liabilities 4,413 4,615 4,705 4,815 Provision 5 5 6 6 Total current liabilities 4,418 4,620 4,711 4,821 Other non-current assets 43 34 40 48 Capital Deployed 8,637 8,993 9,746 10,602 3

Cash Flow Statement PBT 1,156 998 1,261 1,491 Depreciation 390 410 463 515 Interest provided 329 329 320 296 Other non-cash adjustments 16 Operating CF before WC requirement 1,875 1,753 2,044 2,302 Change in working capital 566 443 468 682 Tax Paid 406 357 416 477 Operating cash flow 903 953 1,159 1,143 FCF 324 583 589 613 Capex 579 370 571 530 Investments 3 6 - - Investing cash flow (582) (376) (571) (530) Issue/buyback of equity 21 17 - - Issue/repayment of debt (231) (335) (255) (285) Dividends paid 28 15 15 15 Interest paid (329) (329) (320) (296) Financing cash flow (567) (662) (589) (595) Opening cash balance 678 432 348 347 Net change in cash (246) (84) (1) 18 Closing cash balance 432 348 347 365 Key Ratios Y/E March FY16 FY17 FY18E FY19E Profitablity/Return Ratio (x) EBITDA margins (%) 13.2 12.4 13.0 12.9 PBT margins (%) 8.4 7.5 8.3 8.7 PAT margins (%) 5.5 4.8 5.6 6.0 Tax Rate (%) 33.6 33.5 33.5 33.5 ROCE (%) 17.2 14.8 16.2 16.9 RONW (%) 13.6 10.4 12.1 12.7 Debt/Equity Ratio (X) 0.5 0.4 0.4 0.3 Per Share Data (Rs) EPS (Rs) 51.2 43.9 57.9 69.5 Book Value 377.3 422.0 478.9 547.3 DPS 1.9 1.0 1.0 1.0 Valuation Ratio (x) PE 15.1 17.6 13.4 11.2 PBV 2.1 1.8 1.6 1.4 EV/EBITDA 7.7 8.3 7.0 6.1 Ev/Sales 1.0 1.0 0.9 0.8 4

Rating Guides Rating Expected absolute returns (%) over 12 months BUY >10% -5% to 10% REDUCE >-5% Reliance Securities Limited (RSL), the broking arm of Reliance Capital is one of the India s leading retail broking houses. Reliance Capital is amongst India s leading and most valuable financial services companies in the private sector. Reliance Capital has interests in asset management and mutual funds, life and general insurance, commercial finance, equities and commodities broking, wealth management services, distribution of financial products, private equity, asset reconstruction, proprietary investments and other activities in financial services. The list of associates of RSL is available on the website www.reliancecapital.co.in. RSL is registered as a Research Analyst under SEBI (Research Analyst) Regulations, 2014 General Disclaimers: This Research Report (hereinafter called Report ) is prepared and distributed by RSL for information purposes only. The recommendations, if any, made herein are expression of views and/or opinions and should not be deemed or construed to be neither advice for the purpose of purchase or sale of any security, derivatives or any other security through RSL nor any solicitation or offering of any investment /trading opportunity on behalf of the issuer(s) of the respective security(ies) referred to herein. These information / opinions / views are not meant to serve as a professional investment guide for the readers. No action is solicited based upon the information provided herein. Recipients of this Report should rely on information/data arising out of their own investigations. Readers are advised to seek independent professional advice and arrive at an informed trading/investment decision before executing any trades or making any investments. This Report has been prepared on the basis of publicly available information, internally developed data and other sources believed by RSL to be reliable. RSL or its directors, employees, affiliates or representatives do not assume any responsibility for, or warrant the accuracy, completeness, adequacy and reliability of such information / opinions / views. While due care has been taken to ensure that the disclosures and opinions given are fair and reasonable, none of the directors, employees, affiliates or representatives of RSL shall be liable for any direct, indirect, special, incidental, consequential, punitive or exemplary damages, including lost profits arising in any way whatsoever from the information / opinions / views contained in this Report. Risks: Trading and investment in securities are subject to market risks. There are no assurances or guarantees that the objectives of any of trading / investment in securities will be achieved. The trades/ investments referred to herein may not be suitable to all categories of traders/investors. The names of securities mentioned herein do not in any manner indicate their prospects or returns. The value of securities referred to herein may be adversely affected by the performance or otherwise of the respective issuer companies, changes in the market conditions, micro and macro factors and forces affecting capital markets like interest rate risk, credit risk, liquidity risk and reinvestment risk. Derivative products may also be affected by various risks including but not limited to counter party risk, market risk, valuation risk, liquidity risk and other risks. Besides the price of the underlying asset, volatility, tenor and interest rates may affect the pricing of derivatives. Disclaimers in respect of jurisdiction: The possession, circulation and/or distribution of this Report may be restricted or regulated in certain jurisdictions by appropriate laws. No action has been or will be taken by RSL in any jurisdiction (other than India), where any action for such purpose(s) is required. Accordingly, this Report shall not be possessed, circulated and/ or distributed in any such country or jurisdiction unless such action is in compliance with all applicable laws and regulations of such country or jurisdiction. RSL requires such recipient to inform himself about and to observe any restrictions at his own expense, without any liability to RSL. Any dispute arising out of this Report shall be subject to the exclusive jurisdiction of the Courts in India. Disclosure of Interest: The research analysts who have prepared this Report hereby certify that the views /opinions expressed in this Report are their personal independent views/opinions in respect of the securities and their respective issuers. None of RSL, research analysts, or their relatives had any known direct /indirect material conflict of interest including any long/short position(s) in any specific security on which views/opinions have been made in this Report, during its preparation. RSL s Associates may have other potential/material conflict of interest with respect to any recommendation and related information and opinions at the time of publication of research report. RSL, its Associates, the research analysts, or their relatives might have financial interest in the issuer company(ies) of the said securities. RSL or its Associates may have received a compensation from the said issuer company(ies) in last 12 months for the brokerage or non brokerage services.rsl, its Associates, the research analysts or their relatives have not received any compensation or other benefits directly or indirectly from the said issuer company(ies) or any third party in last 12 months in any respect whatsoever for preparation of this report. The research analysts has served as an officer, director or employee of the said issuer company(ies)?: No RSL, its Associates, the research analysts or their relatives holds ownership of 1% or more, in respect of the said issuer company(ies).?: No Copyright: The copyright in this Report belongs exclusively to RSL. This Report shall only be read by those persons to whom it has been delivered. No reprinting, reproduction, copying, distribution of this Report in any manner whatsoever, in whole or in part, is permitted without the prior express written consent of RSL. RSL s activities were neither suspended nor have defaulted with any stock exchange with whom RSL is registered. Further, there does not exist any material adverse order/judgments/ strictures assessed by any regulatory, government or public authority or agency or any law enforcing agency in last three years. Further, there does not exist any material enquiry of whatsoever nature instituted or pending against RSL as on the date of this Report. Important These disclaimers, risks and other disclosures must be read in conjunction with the information / opinions / views of which they form part of. RSL CIN: U65990MH2005PLC154052. SEBI registration no. ( Stock Brokers: NSE - INB / INF / INE 231234833; BSE - INB / INF / INE 011234839, Depository Participants: CDSL IN-DP-257-2016 IN-DP-NSDL-363-2013, Research Analyst: INH000002384); AMFI ARN No.29889. 5